⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

August 13, 2024Parkinsonism & Related DisordersOpen Access

Safinamide effect on sleep architecture of motor fluctuating Parkinson’s disease patients: a polysomnographic rasagiline-controlled study.

Roberta Bovenzi Matteo Conti Mariangela Pierantozzi Greta Testone Mariana Fernandes Natalia Manfredi Tommaso Schirinzi Rocco Cerroni Nicola Biagio Mercuri Alessandro Stefani Claudio Liguori

View Full Paper

Ask AI

Bookmark

Share

Abstract

Sleep problems commonly occur in Parkinson's disease (PD) and significantly affect patients' quality of life. A possible effect on subjective sleep disturbances of monoamine oxidase-B inhibitors (MAOB-Is) has been described.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Bovenzi et al. (2024) studied this question.

synapsesocial.com/papers/68e5c757b6db64358755de0a https://doi.org/10.1016/j.parkreldis.2024.107103

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1A dual timeline of safinamide effects in Parkinson’s disease: mechanistic rationale and clinical implicationsHuman Clinical Trial · 2026
2Rasagiline does not exacerbate autonomic blood pressure dysregulation in early or mild Parkinson’s diseasecohort · 2021 · 3 citations
3Evaluation of the efficacy and cost-effectiveness of safinamide versus rasagiline: a systematic review.2025
4Effects of <scp>MAO</scp> ‐B Inhibitors on Cognition in Patients with Parkinson's Disease: A Systematic Network Meta‐AnalysisRandomized Controlled Trial · 2026
5Use of safinamide for treatment of Parkinson disease: real-world data from Spain2025